Induction of abortion by intrauterine administration of prostaglandin F2 alpha and histopathological studies of gestational sac.
D000028:Abortion, Induced; D000653:Amniotic Fluid; D002404:Catheterization; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004487:Edema / Q000139:chemically induced; D005321:Extraembryonic Membranes / Q000503:physiopathology; D005260:Female; D005334:Fever / Q000139:chemically induced; D006801:Humans; D010920:Placenta / Q000503:physiopathology; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011262:Pregnancy Trimester, Second; D011453:Prostaglandins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D014599:Uterus / Q000601:surgery; D014839:Vomiting / Q000139:chemically induced
D011453:Prostaglandins